Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

CNN-based PET sinogram repair to mitigate defective block detectors.

Whiteley WJ, Gregor J.

Phys Med Biol. 2019 Sep 30. doi: 10.1088/1361-6560/ab4919. [Epub ahead of print]

PMID:
31569075
2.

Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein Expression.

Wilson A, Urquhart BL, Ponich T, Chande N, Gregor JC, Beaton M, Kim RB.

Mol Pharm. 2019 Sep 3;16(9):4059-4064. doi: 10.1021/acs.molpharmaceut.9b00459. Epub 2019 Aug 19.

PMID:
31393129
3.

Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.

Al Draiweesh S, Ma C, Gregor JC, Rahman A, Jairath V.

Inflamm Bowel Dis. 2019 Aug 20;25(9):e109. doi: 10.1093/ibd/izz087. No abstract available.

PMID:
30990222
4.

Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies.

Ma C, Guizzetti L, Cipriano LE, Parker CE, Nguyen TM, Gregor JC, Chande N, Feagan BG, Jairath V.

Aliment Pharmacol Ther. 2019 Feb;49(4):364-374. doi: 10.1111/apt.15090. Epub 2018 Dec 19. Review.

PMID:
30569460
5.

Respiratory Motion Correction Using A Novel Positron Emission Particle Tracking Technique: A Framework Towards Individual Lesion-Based Motion Correction.

Tumpa TR, Acuff SN, Gregor J, Lee S, Hu D, Osborne DR.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:5249-5252. doi: 10.1109/EMBC.2018.8513486.

PMID:
30441522
6.

Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.

Ma C, Dutton SJ, Cipriano LE, Singh S, Parker CE, Nguyen TM, Guizzetti L, Gregor JC, Chande N, Hindryckx P, Feagan BG, Jairath V.

Aliment Pharmacol Ther. 2018 Jul;48(2):114-126. doi: 10.1111/apt.14821. Epub 2018 May 30.

PMID:
29851091
7.

Impact assessment of pollutants from waste-related operations as a feature of holistic logistic tool.

Nevrlý V, Šomplák R, Gregor J, Pavlas M, Klemeš JJ.

J Environ Manage. 2018 Aug 15;220:77-86. doi: 10.1016/j.jenvman.2018.05.003. Epub 2018 May 12.

PMID:
29763792
8.

Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: results of a prospective cross-sectional willingness-to-pay study.

Gregor JC, Williamson M, Dajnowiec D, Sattin B, Sabot E, Salh B.

Patient Prefer Adherence. 2018 Apr 10;12:505-513. doi: 10.2147/PPA.S152872. eCollection 2018.

9.

Presence of Melena in Obscure Gastrointestinal Bleeding Predicts Bleeding in the Proximal Small Intestine.

Zhu CN, Friedland J, Yan B, Wilson A, Gregor J, Jairath V, Sey M.

Dig Dis Sci. 2018 May;63(5):1280-1285. doi: 10.1007/s10620-018-5003-x. Epub 2018 Mar 8.

PMID:
29516329
10.

Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype? Authors' reply.

Wilson A, Jansen LE, Rose RV, Gregor JC, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft WA, Kim RB.

Aliment Pharmacol Ther. 2018 Apr;47(7):1044-1045. doi: 10.1111/apt.14562. No abstract available.

11.

HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.

Wilson A, Jansen LE, Rose RV, Gregor JC, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft WA, Kim RB.

Aliment Pharmacol Ther. 2018 Mar;47(5):615-620. doi: 10.1111/apt.14483. Epub 2017 Dec 22.

12.

Insertion of percutaneous endoscopic gastrostomy tubes with jejunal extensions using the "wedge" technique: a novel method to prevent retrograde tube migration into the stomach.

Sey MSL, Gregor H, Gregor J, Yan B.

Endoscopy. 2017 Dec;49(12):1251-1255. doi: 10.1055/s-0043-118095. Epub 2017 Sep 12.

PMID:
28898918
13.

Predictors of quality of life in Czech female breast cancer survivors following treatment with special interest to coping strategies.

Jarkovský J, Skřivanová K, Benešová K, Šnajdrová L, Gregor J, Peterková H, Bendová M, Brančíková D, Elfmarková N, Svěrák T, Anderková Ľ, Minář L, Protivánková M, Nedvěd J, Dušek L, Temoshok L.

Vnitr Lek. Summer 2017;63(6):389-396.

PMID:
28840734
14.

The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.

Kwapisz L, Gregor J, Chande N, Yan B, Ponich T, Mosli M.

Scand J Gastroenterol. 2017 Aug;52(8):846-850. doi: 10.1080/00365521.2017.1315740. Epub 2017 Apr 20.

PMID:
28423962
15.

The structural basis for calcium inhibition of lipid kinase PI4K IIalpha and comparison with the apo state.

Baumlova A, Gregor J, Boura E.

Physiol Res. 2016 Dec 13;65(6):987-993. Epub 2016 Aug 19.

16.

The Utility of Endoscopic Biopsies in Patients with Normal Upper Endoscopy.

Teriaky A, AlNasser A, McLean C, Gregor J, Yan B.

Can J Gastroenterol Hepatol. 2016;2016:3026563. doi: 10.1155/2016/3026563. Epub 2016 Jul 10.

17.

Efficiency and patient experience with propofol vs conventional sedation: A prospective study.

Thornley P, Al Beshir M, Gregor J, Antoniou A, Khanna N.

World J Gastrointest Endosc. 2016 Feb 25;8(4):232-8. doi: 10.4253/wjge.v8.i4.232.

18.

Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.

Al-Judaibi B, Schwarz UI, Huda N, Dresser GK, Gregor JC, Ponich T, Chande N, Mosli M, Kim RB.

J Popul Ther Clin Pharmacol. 2016;23(1):e26-36. Epub 2016 Feb 22.

PMID:
26950049
19.

Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.

Kwapisz L, Mosli M, Chande N, Yan B, Beaton M, Micsko J, Mennill PW, Barnett W, Bax K, Ponich T, Howard J, Tirolese A, Lannigan R, Gregor J.

Saudi J Gastroenterol. 2015 Nov-Dec;21(6):360-6. doi: 10.4103/1319-3767.170948.

20.

Comparison of SIRT and SQS for Regularized Weighted Least Squares Image Reconstruction.

Gregor J, Fessler JA.

IEEE Trans Comput Imaging. 2015 Mar;1(1):44-55. Epub 2015 Jun 5.

21.

Efficacy of Coral Sand for Removal of and Bacteriophage under Saturated Flow Conditions.

Burbery L, Weaver L, Humphries B, Gregor J.

J Environ Qual. 2015 Sep;44(5):1384-91. doi: 10.2134/jeq2015.01.0044.

PMID:
26436256
22.

GATE validation of standard dual energy corrections in small animal SPECT-CT.

Lee S, Gregor J, Kennel SJ, Osborne DR, Wall J.

PLoS One. 2015 Apr 7;10(4):e0122780. doi: 10.1371/journal.pone.0122780. eCollection 2015.

23.

Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST).

Sandhu A, Mosli M, Yan B, Wu T, Gregor J, Chande N, Ponich T, Beaton M, Rahman A.

JPEN J Parenter Enteral Nutr. 2016 May;40(4):507-10. doi: 10.1177/0148607114566656. Epub 2015 Jan 28.

PMID:
25632031
24.

[New European Information and Communication Platform Striving for Improved Care for Colorectal Cancer Patients - www.crcprevention.eu].

Dušek L, Poc P, Májek O, Suchánek S, Seifert B, Gregor J, Zavoral M.

Klin Onkol. 2014;27 Suppl 2:131-7. Czech.

PMID:
25494899
25.

[Role and importance of civil society organisations in the support of cancer screening].

Gregor J, Májek O, Dušek L, Snajdrová L.

Klin Onkol. 2014;27 Suppl 2:128-30. Review. Czech.

PMID:
25494898
26.

[National web portals as an official communication platform of cancer screening programmes].

Gregor J, Dušek L, Májek O, Snajdrová L.

Klin Onkol. 2014;27 Suppl 2:124-7. Czech.

PMID:
25494897
27.

[Approach to population-based screening in the Czech Republic, methodology and first results of the personalised invitation of citizens to cancer screening programmes].

Dušek L, Májek O, Bláha M, Daneš J, Zavoral M, Seifert B, Dvořák V, Skovajsová M, Suchánek S, Jung T, Brzková M, Klika P, Klimeš D, Koptíková J, Gregor J.

Klin Onkol. 2014;27 Suppl 2:59-68. Czech.

PMID:
25494890
28.

[State and development of background information for the evaluation of Czech cancer screening programmes].

Dušek L, Májek O, Klimeš D, Bláha M, Brabec P, Gregor J.

Klin Onkol. 2014;27 Suppl 2:49-58. Czech.

PMID:
25494889
29.

[Epidemiology of cancers with implemented screening programmes in an international comparison].

Dušek L, Mužík J, Malúšková D, Gregor J.

Klin Onkol. 2014;27 Suppl 2:40-8. Czech.

PMID:
25494888
30.

[Epidemiology of screening-targeted cancers according to new data of the Czech National Cancer Registry].

Dušek L, Mužík J, Malúšková D, Májek O, Pavlík T, Koptíková J, Gregor J, Brabec P, Abrahámová J.

Klin Onkol. 2014;27 Suppl 2:19-39. Czech.

PMID:
25494887
31.

[Objective need for cancer prevention in the Czech Republic and Europe, and the state thereof].

Dušek L, Májek O, Mužík J, Pavlík T, Koptíková J, Gregor J.

Klin Onkol. 2014;27 Suppl 2:7-18. Czech.

PMID:
25494886
32.

Opioid use is associated with decreased quality of life in patients with Crohn's disease.

Sanford D, Thornley P, Teriaky A, Chande N, Gregor J.

Saudi J Gastroenterol. 2014 May-Jun;20(3):182-7. doi: 10.4103/1319-3767.133020.

33.

Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada.

Benchimol EI, Guttmann A, Mack DR, Nguyen GC, Marshall JK, Gregor JC, Wong J, Forster AJ, Manuel DG.

J Clin Epidemiol. 2014 Aug;67(8):887-96. doi: 10.1016/j.jclinepi.2014.02.019. Epub 2014 Apr 26.

PMID:
24774473
34.

[Psychoneuroimmunology in context of comprehensive breast cancer treatment].

Skřivanová K, Gregor J, Bendová M, Brančíková D, Elfmarková N, Svěrák T, Peterková H, Dušek L.

Klin Onkol. 2014;27(2):103-7. Review. Czech.

PMID:
24739046
35.

Computer-based virtual reality colonoscopy simulation improves patient-based colonoscopy performance.

McIntosh KS, Gregor JC, Khanna NV.

Can J Gastroenterol Hepatol. 2014 Apr;28(4):203-6.

36.

Use of technology for note taking and therapeutic alliance.

Wiarda NR, McMinn MR, Peterson MA, Gregor JA.

Psychotherapy (Chic). 2014 Sep;51(3):443-6. doi: 10.1037/a0035075. Epub 2013 Dec 30.

PMID:
24377404
37.

The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre.

Teriaky A, Gregor J, Yan B, Ponich T, Chande N, Mosli M.

Scand J Gastroenterol. 2014 Mar;49(3):280-6. doi: 10.3109/00365521.2013.865785. Epub 2013 Dec 16.

PMID:
24329040
38.

Follow-up of participants in the Canadian Association of Gastroenterology Scholars' Program, 2006 to 2012.

Lam MC, Sey MS, Gregor J, Wong C.

Can J Gastroenterol Hepatol. 2014 Feb;28(2):94-6. Epub 2013 Nov 28.

39.
40.

Transcutaneous bowel sonography for inflammatory bowel disease is sensitive and specific when performed in a nonexpert low-volume North American center.

Sey MS, Gregor J, Chande N, Ponich T, Bhaduri M, Lum A, Zaleski W, Yan B.

J Ultrasound Med. 2013 Aug;32(8):1413-7. doi: 10.7863/ultra.32.8.1413.

PMID:
23887951
41.

Interactive algorithms for teaching and learning acute medicine in the network of medical faculties MEFANET.

Schwarz D, Štourač P, Komenda M, Harazim H, Kosinová M, Gregor J, Hůlek R, Smékalová O, Křikava I, Štoudek R, Dušek L.

J Med Internet Res. 2013 Jul 8;15(7):e135. doi: 10.2196/jmir.2590.

42.

Retrospective analysis of disease association and outcome in histologically confirmed ischemic colitis.

Mosli M, Parfitt J, Gregor J.

J Dig Dis. 2013 May;14(5):238-43. doi: 10.1111/1751-2980.12045.

PMID:
23419044
43.

Wait times for diagnostic colonoscopy among outpatients with colorectal cancer: a comparison with Canadian Association of Gastroenterology targets.

Sey MS, Gregor J, Adams P, Khanna N, Vinden C, Driman D, Chande N.

Can J Gastroenterol. 2012 Dec;26(12):894-6.

44.

Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.

Wilson A, Patel V, Chande N, Ponich T, Urquhart B, Asher L, Choi Y, Tirona R, Kim RB, Gregor JC.

Aliment Pharmacol Ther. 2013 Feb;37(3):340-5. doi: 10.1111/apt.12161. Epub 2012 Nov 28.

45.

Case study on live cell apoptosis-assay using lamin-chromobody cell-lines for high-content analysis.

Zolghadr K, Gregor J, Leonhardt H, Rothbauer U.

Methods Mol Biol. 2012;911:569-75. doi: 10.1007/978-1-61779-968-6_36.

PMID:
22886277
46.

Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database.

Poprach A, Bortlíček Z, Büchler T, Melichar B, Lakomý R, Vyzula R, Brabec P, Svoboda M, Dušek L, Gregor J.

Med Oncol. 2012 Dec;29(5):3314-20. doi: 10.1007/s12032-012-0286-9. Epub 2012 Jun 30.

PMID:
22752571
47.

Nonutility of routine testing of stool for ova and parasites in a tertiary care Canadian centre.

Mosli M, Gregor J, Chande N, Lannigan R.

Can J Microbiol. 2012 May;58(5):653-9. doi: 10.1139/w2012-039. Epub 2012 Apr 27.

PMID:
22540249
48.

Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation.

Thirumaran RK, Lamba JK, Kim RB, Urquhart BL, Gregor JC, Chande N, Fan Y, Qi A, Cheng C, Thummel KE, Hall SD, Schuetz EG.

Biochem Pharmacol. 2012 Jul 1;84(1):104-12. doi: 10.1016/j.bcp.2012.03.017. Epub 2012 Mar 30.

49.

Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions.

Teriaky A, Gregor J, Chande N.

Saudi J Gastroenterol. 2012 Mar-Apr;18(2):95-8. doi: 10.4103/1319-3767.93808.

50.

Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).

Ho RH, Leake BF, Urquhart BL, Gregor JC, Dawson PA, Kim RB.

J Gastroenterol Hepatol. 2011 Dec;26(12):1740-8. doi: 10.1111/j.1440-1746.2011.06805.x.

Supplemental Content

Loading ...
Support Center